Correlation Between China SXT and Zynerba Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both China SXT and Zynerba Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Zynerba Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between China SXT Pharmaceuticals and Zynerba Pharmaceuticals, you can compare the effects of market volatilities on China SXT and Zynerba Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Zynerba Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Zynerba Pharmaceuticals.

Diversification Opportunities for China SXT and Zynerba Pharmaceuticals

0.3

Correlation Coefficient

China SXT  Zynerba Pharmaceuticals

Weak diversification

The 3 months correlation between China and Zynerba is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Zynerba Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zynerba Pharmaceuticals and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Zynerba Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zynerba Pharmaceuticals has no effect on the direction of China SXT i.e., China SXT and Zynerba Pharmaceuticals go up and down completely randomly.

Pair Corralation between China SXT and Zynerba Pharmaceuticals

If you would invest  36.00  in Zynerba Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of  0.00  from holding Zynerba Pharmaceuticals or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	0.37%
Values	Daily Returns

China SXT Pharmaceuticals  vs.  Zynerba Pharmaceuticals

China SXT Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Zynerba Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zynerba Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Zynerba Pharmaceuticals is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with China SXT and Zynerba Pharmaceuticals

The main advantage of trading using opposite China SXT and Zynerba Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Zynerba Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zynerba Pharmaceuticals will offset losses from the drop in Zynerba Pharmaceuticals' long position.

The idea behind China SXT Pharmaceuticals and Zynerba Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.